Clinical Establishments Act 2010 Hospital Pharmacy Compliance Audit
This checklist covers compliance requirements under New Drugs & Clinical Trial Rules 2019 and applicable Indian regulations for healthcare operations. Non-compliance can result in cancellation of manufacturing licence and penalties up to ₹10 lakh under Section 27 of the Drugs & Cosmetics Act 1940.
- Industry: Healthcare
- Frequency: Quarterly
- Estimated Time: 25-35 minutes
- Role: Pharmacy Director
- Total Items: 20
- Compliance: New Drugs & Clinical Trial Rules 2019, ICH E6 GCP, CDSCO Guidelines, Schedule Y
CDSCO Licence & GMP Registration
Verify Drugs & Cosmetics Act 1940 manufacturing licence and Schedule M GMP registration.
- Is the manufacturing licence (Form 25 or 28) valid and current for all products manufactured?
- Is a qualified Technical Staff person (B.Pharm or equivalent) appointed and approved by the licencing authority?
- Is the manufacturing site registered with CDSCO for export and does it comply with Schedule M GMP requirements?
- Attach photo of manufacturing licence Form 25/28, Technical Staff appointment, and CDSCO registration:
Premises, Equipment & Utilities Compliance
Verify GMP premises qualification, utilities, and equipment calibration per Schedule M.
- Are all premises, equipment, and utilities qualified per Schedule M GMP and validation master plan?
- Is the water system (Purified Water or WFI) tested per pharmacopoeial limits with records maintained?
- Are all analytical instruments calibrated with valid calibration certificates on file?
- Attach photo of cleanroom qualification, water system test results, and calibration certificates:
Batch Records & OOS Investigation
Verify BMR completeness, OOS investigation compliance, and QA release per Schedule M.
- Is the batch manufacturing record (BMR) complete, reviewed by QA, and available for every batch?
- Is the out-of-specification (OOS) procedure followed and all OOS investigations documented?
- Overall cGMP production and QA compliance status:
- Attach photo of batch manufacturing record, OOS investigation file, and QA release stamp:
CAPA, Complaints & Pharmacovigilance
Verify CAPA system effectiveness and ADR/pharmacovigilance compliance per CDSCO requirements.
- Is the CAPA system effectively identifying, investigating, and preventing recurrence of quality issues?
- Are product complaints investigated and Adverse Drug Reactions (ADRs) reported to CDSCO PvPI portal?
- Number of open CAPAs beyond target closure date:
- Quality Director or Head of Quality certification:
Corrective Actions & Inspector Sign-Off
Document all deficiencies and assign corrective actions. POPProbe auto-assigns these to team members, generates a signed PDF report instantly, and tracks compliance status across all locations. -> Start free, no credit card required
- List all deficiencies identified in this inspection:
- Overall compliance status?
- Corrective actions assigned to (name and department):
- Inspector digital signature and date:
Related Health Services Checklists
- Drugs & Cosmetics Rules Schedule H1 High-Risk Drug Sales Compliance
- AERB & BARC Radiopharmacy Nuclear Medicine Safety Compliance Audit
- CDSCO Combination Products Drug-Device Regulatory Compliance Audit
- CDSCO CTD Module 4 Non-Clinical Study Reports Compliance Audit
- FSSAI Hospital & Healthcare Facility Kitchen Safety Audit Checklist
- NABH Blood Bank Accreditation Standards Compliance Audit Checklist
- NABH Small Healthcare Organisation SHO Accreditation Audit
- NABH Dental Care Standards Accreditation Compliance Checklist
Related Pharmaceutical Checklists
- Medical Devices Rules 2017 Schedule 3 QMS Audit Checklist - FREE Download
- New Drugs & Clinical Trial Rules 2019 GCP Compliance Audit Checklist - FREE Download
- ISO 13485:2016 & Medical Devices Rules 2017 India QMS Audit - FREE Download
- New Drugs & Clinical Trials Rules 2019 Clinical Site GCP Inspection - FREE Download
- Drugs & Cosmetics Act Blood Bank Annual Licence Renewal Audit - FREE Download
- Medical Devices Rules 2017 Post-Market Surveillance Plan Audit - FREE Download
- Drugs & Cosmetics Rules Schedule H1 High-Risk Drug Sales Compliance - FREE Download
- AERB & BARC Radiopharmacy Nuclear Medicine Safety Compliance Audit - FREE Download
- CDSCO Combination Products Drug-Device Regulatory Compliance Audit - FREE Download
- CDSCO CTD Module 4 Non-Clinical Study Reports Compliance Audit - FREE Download
Why Use This Clinical Establishments Act 2010 Hospital Pharmacy Compliance Audit?
This clinical establishments act 2010 hospital pharmacy compliance audit helps healthcare teams maintain compliance and operational excellence. Designed for pharmacy director professionals, this checklist covers 20 critical inspection points across 5 sections. Recommended frequency: quarterly.
Ensures compliance with New Drugs & Clinical Trial Rules 2019, ICH E6 GCP, CDSCO Guidelines, Schedule Y. Regulatory-aligned for audit readiness and inspection documentation.
Frequently Asked Questions
What does the Clinical Establishments Act 2010 Hospital Pharmacy Compliance Audit cover?
This checklist covers 20 inspection items across 5 sections: CDSCO Licence & GMP Registration, Premises, Equipment & Utilities Compliance, Batch Records & OOS Investigation, CAPA, Complaints & Pharmacovigilance, Corrective Actions & Inspector Sign-Off. It is designed for healthcare operations and compliance.
How often should this checklist be completed?
This checklist should be completed quarterly. Each completion takes approximately 25-35 minutes.
Who should use this Clinical Establishments Act 2010 Hospital Pharmacy Compliance Audit?
This checklist is designed for Pharmacy Director professionals in the healthcare industry. It can be used for self-assessments, team audits, and regulatory compliance documentation.
Can I download this checklist as a PDF?
Yes, this checklist is available as a free PDF download. You can also use it digitally in the POPProbe mobile app for real-time data capture, photo documentation, and automatic reporting.